European Journal of Cancer
Volume 39, Issue 9 , Pages 1259-1263 , June 2003

Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer

  • V. Kavadas

      Affiliations

    • University Division of Surgery, Level 7, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    • ,
  • J.M. Blazeby

      Affiliations

    • University Division of Surgery, Level 7, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-117-928-2336; fax: +44-117-925-2736
    • ,
  • T. Conroy

      Affiliations

    • Department of Medical Oncology, Centre Alexis Vautrin, Nancy, France
    • ,
  • O. Sezer

      Affiliations

    • Department of Oncology and Haematology, University Hospital Charité, Berlin, Germany
    • ,
  • B. Holzner

      Affiliations

    • Department of Biological Psychiatry, University Clinics Innsbruck, Innsbruck, Austria
    • ,
  • M. Koller

      Affiliations

    • Institute of Theoretical Surgery, Philipps-University Marburg, Marburg, Germany
    • ,
  • J. Buckels

      Affiliations

    • Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    • ,
  • on behalf of the EORTC Quality of Life Group

Received 12 December 2002 ,Accepted 18 February 2003.

References 

  1. Office for National Statistics. Mortality Statistics: Cause 2000 (series DH2) (on-line edition).
  2. Weiss L, Grundmann E, Torhorst J, et al.  Haematogenous metastatic patterns in colonic carcinoma (an analysis of 1541 necropsies). J. Pathol. 1986;160:195–203
  3. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J. Surg. 1995;19:59–71
  4. Aaronson NK, Ahmedzai S, Bergman B, et al.  The European Organization for Research and Treatment of Cancer QLQ-C30 (a quality-of-life instrument for use in international clinical trials in oncology). J. Natl. Cancer Inst. 1993;85:365–376
  5. Cella DF, Tulsky DS, Gray G, et al.  The Functional Assessment of Cancer Therapy scale (development and validation of the general measure). J. Clin. Oncol. 1993;11:570–579
  6. Vickery CW, Blazeby JM, Conroy T, et al.  Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur. J. Cancer. 2001;37:966–971
  7. Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur. J. Cancer. 1999;35:238–247
  8. Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual. Life Res. 1999;8:181–195
  9. Wils J, Sahmoud T, Sobrero A, et al.  Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. Tumori. 1998;84:335–347
  10. Simmonds PC. Palliative chemotherapy for advanced colorectal cancer (systematic review and meta-analysis. Colorectal Cancer Collaborative Group). Br Med J. 2000;341:531–535
  11. Sprangers M, Cull A, Bjordal K, Groenvold M, Aaronson N  on behalf of the EORTC Quality of Life Group. The European Organization for Research and Treatment of Cancer approach to quality of life assessment (guidelines for developing questionnaire modules). Qual. Life Res. 1993;2:287–295
  12. Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules (an update and overview. EORTC Quality of Life Study Group). Qual. Life Res. 1998;7:291–300
  13. Blazeby JM, Alderson D, Winstone K, et al.  Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur. J. Cancer. 1996;32A:1912–1917
  14. Bottomley A, Vachalec S, Bjordal K, et al.  The development and utilisation of the European Organisation for Research and Treatment of cancer quality of life group item bank. Eur. J. Cancer. 2002;38:1611–1614
  15. Cull A, Sprangers M, Bjordal K, Aaronson N., on behalf of the EORTC QoL Study Group. Translation Procedure. Brussels, EORTC Quality of Life Group, 1998.
  16. Heffernan N, Cella D, Webster K, et al.  Measuring health-related quality of life in patients with hepatobiliary cancers (the functional assessment of cancer therapy-hepatobiliary questionnaire). JCO. 2002;20:2229–2239

PII: S0959-8049(03)00236-3

doi: 10.1016/S0959-8049(03)00236-3

European Journal of Cancer
Volume 39, Issue 9 , Pages 1259-1263 , June 2003

Article Tools

* Image Usage & Resolution